Purple Biotech (Israel) Investor Sentiment

KTOV Stock  ILA 6.80  1.70  33.33%   
About 55% of Purple Biotech's investors are presently thinking to get in. The analysis of current outlook of investing in Purple Biotech suggests that some traders are interested regarding Purple Biotech's prospects. The current market sentiment, together with Purple Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Purple Biotech stock news signals to limit their universe of possible portfolio assets.
  
over two weeks ago at news.google.com         
Purple Biotechs Promising Trials and Financial Update - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
How To Trade - Stock Traders Daily
Google News at Macroaxis
over two months ago at news.google.com         
Purple Biotech target adjusted for reverse split at H.C. Wainwright - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Purple Biotech Announces ADS Ratio Change - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference - StockTit...
Google News at Macroaxis
over three months ago at news.google.com         
What Makes Purple Biotech a New Buy Stock - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Purple Biotech Price Target Lowered to 8.00 at HC Wainwright - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Purple Biotech Reveals Promising CM24 Study Results - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Purple Biotech Receives Extension to Regain Compliance with the Nasdaqs Minimum Bid Price Rule - Sto...
Google News at Macroaxis
over three months ago at news.google.com         
Purple Biotech stock retains Buy rating from H.C. Wainwright - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Purple Biotech Shares Up 8.5 percent - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Why Purple Biotech Shares Are Trading Lower - Quantisnow
Google News at Macroaxis
over three months ago at news.google.com         
Purple Biotech Secures 2 Million From Warrants - TipRanks.com - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Why Purple Biotech Shares Are Trading Lower - Purple Biotech - Benzinga
Google News at Macroaxis
over three months ago at news.google.com         
Purple Biotech Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Ca...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Purple Biotech that are available to investors today. That information is available publicly through Purple media outlets and privately through word of mouth or via Purple internal channels. However, regardless of the origin, that massive amount of Purple data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Purple Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Purple Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Purple Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Purple Biotech alpha.

Purple Biotech Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Purple Stock analysis

When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules